Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3847685

CS(=O)(=O)c1ccccc1N1CCN(c2ncnc3ccc(-c4cn[nH]c4)cc23)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.50
CYP3A4 P08684 13/20 0.43
HPGD P15428 2/20 0.43
CYP1A2 P05177 12/20 0.43
CLK4 Q9HAZ1 12/20 0.43
ALDH1A1 P00352 9/20 0.43
MAPK1 P28482 8/20 0.43
HIF1A Q16665 8/20 0.43
LMNA P02545 8/20 0.43
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
USP2 O75604 8/20 0.43
CYP2C19 P33261 6/20 0.43
TSHR P16473 5/20 0.43
CYP2D6 P10635 4/20 0.43
ENPP1 P22413 1/20 0.41
ALOX15 P16050 2/20 0.41
HSD17B10 Q99714 4/20 0.40
KDM4E B2RXH2 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3855195 0.89 ENPP1 (0.49) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3847329 0.88 AKT1 (0.53) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3856624 0.88 AKT1 (0.52) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3848208 0.88 AKT1 (0.53) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3855532 0.85 AKT1 (0.51) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3851492 0.85 AKT1 (0.51) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3847446 0.85 AKT1 (0.49) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3852124 0.83 AKT1 (0.57) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3850032 0.82 AKT1 (0.53) AKT1CYP3A4HPGDCYP1A2CLK4
Trifluoroacetic Acid SCHEMBL3851634 0.82 AKT1 (0.48) AKT1CYP3A4HPGDCYP1A2CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed